Molecular Templates, Inc.

Investor Relations

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending December 31, 2023

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Learn More

Company Overview

Molecular Templates is focused on the discovery, development, and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.

Investor Contact Information


Molecular Templates, Inc.
9301 Amberglen Blvd
Suite 100
Austin, TX 78729

Investor Relations

Dr. Grace Kim

Transfer Agent

PO Box 358015
Pittsburgh, PA 15252
T: 781-575-3120